Beijing Airdoc Technology Co., Ltd.

SEHK:2251 Stock Report

Market Cap: HK$1.7b

Beijing Airdoc Technology Past Earnings Performance

Past criteria checks 0/6

Beijing Airdoc Technology's earnings have been declining at an average annual rate of -24.2%, while the Healthcare Services industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 34.7% per year.

Key information

-24.2%

Earnings growth rate

1.3%

EPS growth rate

Healthcare Services Industry Growth22.3%
Revenue growth rate34.7%
Return on equity-9.4%
Net Margin-65.0%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Investors Appear Satisfied With Beijing Airdoc Technology Co., Ltd.'s (HKG:2251) Prospects As Shares Rocket 33%

Apr 03
Investors Appear Satisfied With Beijing Airdoc Technology Co., Ltd.'s (HKG:2251) Prospects As Shares Rocket 33%

Are Investors Undervaluing Beijing Airdoc Technology Co., Ltd. (HKG:2251) By 49%?

Mar 02
Are Investors Undervaluing Beijing Airdoc Technology Co., Ltd. (HKG:2251) By 49%?

We Think Beijing Airdoc Technology (HKG:2251) Can Afford To Drive Business Growth

Feb 02
We Think Beijing Airdoc Technology (HKG:2251) Can Afford To Drive Business Growth

The Beijing Airdoc Technology Co., Ltd. (HKG:2251) Analysts Have Been Trimming Their Sales Forecasts

Sep 19
The Beijing Airdoc Technology Co., Ltd. (HKG:2251) Analysts Have Been Trimming Their Sales Forecasts

Calculating The Intrinsic Value Of Beijing Airdoc Technology Co., Ltd. (HKG:2251)

Sep 01
Calculating The Intrinsic Value Of Beijing Airdoc Technology Co., Ltd. (HKG:2251)

We're Not Very Worried About Beijing Airdoc Technology's (HKG:2251) Cash Burn Rate

Jun 09
We're Not Very Worried About Beijing Airdoc Technology's (HKG:2251) Cash Burn Rate

Revenue & Expenses Breakdown
Beta

How Beijing Airdoc Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:2251 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23204-133209112
30 Sep 23181-125197112
30 Jun 23159-117184113
31 Mar 23136-149182119
31 Dec 22114-180180126
30 Sep 22108-192181118
30 Jun 22103-205181110
31 Mar 22109-17416687
31 Dec 21115-14315064
30 Sep 21103-10211357
30 Jun 2191-627649
31 Mar 2169-566046
31 Dec 2048-504442
31 Dec 1930-472940

Quality Earnings: 2251 is currently unprofitable.

Growing Profit Margin: 2251 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2251 is unprofitable, and losses have increased over the past 5 years at a rate of 24.2% per year.

Accelerating Growth: Unable to compare 2251's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2251 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.5%).


Return on Equity

High ROE: 2251 has a negative Return on Equity (-9.35%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.